Accelerating SARS-CoV-2 genomic surveillance efforts
To combat the COVID-19 pandemic, researchers require rapid solutions for SARS-CoV-2 genomic surveillance. When studying emerging variants, tracing existing outbreaks and advancing research into vaccines and drug development, every second counts. It may be difficult to keep pace with new developments when resources and time are limited.
QIAGEN Genomic Services has risen to meet this need with our comprehensive SARS-CoV-2 Whole Genome Sequencing Services. Extend your in-house resources with the expertise and custom services that you expect from QIAGEN. This all-in-one genome sequencing solution delivers end-to-end support, from sample preparation to data analysis, to help accelerate your research.
Our SARS-CoV-2 Whole Genome Sequencing Service offers the following benefits:
- End-to-end service: We take care of every step, from sample preparation to data analysis
- Guidance and flexibility: We aid in designing your project and help you make the right decisions
- Expertise in SARS-CoV-2 genomics: We leverage our optimized QIAseq SARS-CoV-2 Primer Panel to efficiently sequence the entire viral genome
- Ready-to-publish data: We deliver comprehensive reports and data packages
Explore what our service has to offer
Need support for SARS-CoV-2 surveillance?
Our dedicated team of experts can take care of your whole genome sequencing needs to advance your SARS-CoV-2 variant studies.